查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2010008

動物用藥品市場：2026-2032年全球市場預測（依動物種類、產品類型、治療應用、通路和最終用戶分類）

Animal Health Market by Animal Type, Product, Therapeutic Application, Distribution Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，動物用藥品市場價值將達到 985 億美元，到 2026 年將成長至 1,062.2 億美元，到 2032 年將達到 1,763 億美元，複合年成長率為 8.67%。

主要市場統計數據
基準年 2025 985億美元
預計年份：2026年 1062.2億美元
預測年份 2032 1763億美元
複合年成長率 (%) 8.67%

簡要概述不斷發展的動物醫療保健生態系統，重點關注正在重塑臨床環境、供應鏈和相關人員之間合作的促進因素。

目前動物保健領域正處於公共衛生、食品安全和伴侶動物福利三大關鍵領域的交匯點。寵物數量的不斷成長、畜牧生產系統的日益複雜化以及公眾對通用感染疾病風險意識的提高，都推動了對有效的預防和治療方案的需求。同時，監管監督和管理工作正在重塑產品的研發、核准和推廣方式，而這與物種或用途無關。

整個動物保健產業正在經歷重大的結構和技術變革，這些變革正在重新定義產品創新、臨床實踐和分銷管道。

目前，該產業正經歷一場變革，這場變革正在重新定義臨床實務、研究重點和經營模式。數位轉型正在加速伴侶動物遠端醫療平台和牲畜遠距監測工具的普及，使臨床醫生和生產者能夠更快、更準確地做出數據驅動的決策。精準畜牧技術，例如感測器和基因組分析工具，正在透過早期療育最佳化生產力和飼料轉換率，同時降低疾病發生率。

本研究評估了美國關稅政策的變化將如何影響動物健康相關人員。

美國關稅政策預計將於2025年進行調整，這可能對動物保健產業產生複雜的影響，遠不止於直接的成本壓力。關稅變化往往會增加進口原料和成品的成本，從而可能擠壓依賴國際供應鏈的製造商的利潤空間。為了因應這種情況，企業通常會調整籌資策略，轉向本地供應商或擴大國內產能，以降低貿易政策變化所帶來的風險。

透過全面的細分框架所得出的見解，明確了動物種類、產品形式、治療用途、分銷管道和最終用戶行為。

一套精細的細分框架揭示了臨床需求、商業性機會和營運複雜性在整個動物用藥品組合中的交匯點。依動物種類分類，市場涵蓋伴侶動物和家畜。伴侶動物市場主要集中在貓和狗，預防醫學、診斷和慢性病管理佔據主導地位。而家畜市場則包括水產養殖、牛、家禽和豬，每種動物在生物安全、疫苗接種和飼料管理方面都有其獨特的優先事項，這反映了它們各自的生產系統和疾病風險狀況。

影響全球動物保健市場產品引進、供應鏈設計和商業化策略的區域趨勢和法規環境。

區域趨勢對整個動物保健市場的監管、供應鏈和產品採納率都有顯著影響。美洲地區呈現出多元化的特徵：完善的法律規範、成熟的伴侶動物照護市場以及需要嚴格生物安全措施的大規模商業畜牧業。在該地區，私人獸醫診所和一體化生產系統正在推動對診斷、疫苗和飼料最佳化解決方案的需求，而數位化管道正日益成為傳統分銷網路的有力補充。

為了保持競爭優勢，產業領導者正在採取以創新、供應鏈韌性和打入市場策略。

該領域的主要企業正採取策略方針，強調加強研發、多元化產品組合和創新管道。他們正將資源投入新型疫苗平台和分子診斷技術，同時拓展飼料添加劑和生技藥品領域的能力，以應對合理使用抗菌藥物（AMS）的挑戰。製藥開發商與技術供應商之間的策略合作正在加速基於診斷的治療路徑與數位醫療服務的整合。

為動物用藥品產業的企業主管提供切實可行的、有影響力的行動方案，以增強韌性、加速數位化並推動臨床和商業性成果。

動物保健產業的領導者應採取果斷切實可行的措施，在瞬息萬變的環境中掌握機會、規避風險。首先，他們應優先考慮靈活的生產結構和供應商多元化，以減輕政策波動和物流波動的影響。這包括確保關鍵原料的替代來源，投資建設區域生技藥品填充和包裝能力，以及協商能夠根據原料成本波動調整價格的合約條款。

採用透明、多方面的研究途徑，結合一手訪談、第二手資料整合和嚴格的檢驗，以支持策略洞察。

本研究融合了定性和定量方法，以得出嚴謹且切實可行的分析結果。初步研究包括對獸醫、生產經理、採購負責人和行業專家進行結構化訪談，以了解他們對臨床需求、採購因素和分銷挑戰的第一手觀點。作為補充，第二階段研究利用監管文件、科學文獻、專利申請和公開的企業資訊披露，揭示了技術進步和競爭對手的市場定位。

對產業趨勢的簡明扼要、綜合分析突顯了創新、監管和業務永續營運之間的相互作用如何推動未來的動物健康策略。

總之，在技術創新、法規演變和經營模式變革的驅動下，動物保健產業正經歷根本性的重組。診斷技術和疫苗平台的進步、數位醫療和精準農業的興起，以及對合理使用抗菌藥物日益重視，正在重塑產品開發和服務交付模式。同時，供應鏈韌性和區域策略對於保障基本治療和預防產品的可近性至關重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：動物用藥品市場：依動物類型分類

  • 伴侶動物
    • 貓
    • 狗
  • 家畜
    • 水產養殖
    • 牛
    • 家禽
    • 豬

第9章：動物用藥品市場：依產品分類

  • 診斷藥物
    • 免疫學診斷
    • 分子診斷
  • 飼料添加劑
    • 酵素
    • 益生元
    • 益生菌
  • 殺蟲劑
    • 體外寄生蟲控制劑
    • 體內寄生蟲控制劑
  • 製藥
    • 品牌商品
    • 學名藥
  • 疫苗
    • 去活化疫苗
    • 活病毒疫苗
    • 重組

第10章：依治療應用分類的動物用藥品市場

  • 抗感染藥物
    • 抗生素
    • 抗真菌藥物
    • 抗病毒藥物
  • 抗發炎藥
    • 皮質類固醇
    • NSAIDs
  • 驅蟲
    • 體外寄生蟲控制劑
    • 體內寄生蟲控制劑
  • 荷爾蒙製劑
    • 生長激素
    • 生殖荷爾蒙

第11章：動物用藥品市場：依通路分類

  • 網路商店
    • 消費者網站
    • 第三方平台
  • 離線
    • 連鎖藥局
    • 獨立經營藥房

第12章：動物用藥品市場：依最終用戶分類

  • 動物飼主
    • 畜牧業的棋子
    • 寵物飼主
  • 飼料生產商
  • 獸醫
    • 大型動物獸醫
    • 全科獸醫
    • 小動物獸醫

第13章：動物用藥品市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章動物用藥品市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章動物用藥品市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國動物用藥品市場

第17章：中國動物用藥品市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Alltech, Inc.
  • Boehringer Ingelheim International GmbH
  • Cargill, Incorporated
  • Ceva Sante Animale SA
  • Chr. Hansen Holding A/S
  • Covetrus, Inc.
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Heska Corporation
  • HIPRA, SA
  • Huvepharma AD
  • IDEXX Laboratories, Inc.
  • Kemin Industries, Inc.
  • Koninklijke DSM NV
  • Merck & Co., Inc.
  • Neogen Corporation
  • Phibro Animal Health Corporation
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-434CCDA04CF9

The Animal Health Market was valued at USD 98.50 billion in 2025 and is projected to grow to USD 106.22 billion in 2026, with a CAGR of 8.67%, reaching USD 176.30 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 98.50 billion
Estimated Year [2026] USD 106.22 billion
Forecast Year [2032] USD 176.30 billion
CAGR (%) 8.67%

A concise orientation to the evolving animal health ecosystem highlighting drivers that reshape clinical practice, supply chains, and stakeholder collaborations

The contemporary animal health landscape occupies a critical nexus between public health, food security, and companion animal welfare. Rising pet ownership, intensifying livestock production systems, and heightened public awareness of zoonotic risks have elevated demand for robust preventive and therapeutic solutions. At the same time, regulatory scrutiny and stewardship initiatives are reshaping how products are developed, approved, and deployed across species and use cases.

Integration of human and animal health priorities has prompted closer collaboration among veterinarians, producers, and public health authorities, strengthening the One Health framework. Technological advances in diagnostics, biologics, and data analytics are enabling earlier detection of disease, more precise interventions, and improved monitoring of treatment outcomes. Meanwhile, consumer-driven preferences for sustainability, transparency, and reduced antimicrobial use are influencing product development pathways and commercial strategies.

Transitioning from traditional models, the sector now emphasizes resilience: diversified supply chains, digital-enabled service delivery, and cross-disciplinary R&D partnerships. These trends require stakeholders to reassess capabilities across research, manufacturing, distribution, and field services. As emerging technologies and policy shifts converge, leaders must balance immediate clinical needs with long-term strategic positioning to safeguard animal health and related human health objectives.

Major structural and technological shifts are redefining product innovation, clinical practice, and distribution channels across the animal health industry

The industry is in the midst of transformative shifts that are redefining clinical practice, research priorities, and commercial models. Digital transformation is accelerating adoption of telemedicine platforms for companion animals and remote monitoring tools for livestock, enabling clinicians and producers to make data-driven decisions with greater speed and precision. Precision livestock farming technologies, including sensors and genomic tools, are reducing disease incidence through earlier intervention while optimizing productivity and feed efficiency.

In product innovation, biologics and recombinant vaccine platforms are gaining traction alongside next-generation diagnostics that bring molecular testing closer to point-of-care settings. There is also a clear pivot toward feed additives that support gut health and immunity, reflecting a broader move to reduce reliance on traditional antibiotics. Concurrently, regulatory and antimicrobial stewardship programs are increasing demand for alternative therapies and tightened labeling and usage protocols.

Commercially, consolidation among suppliers and strategic partnerships between pharmaceutical developers and technology providers are reshaping competitive dynamics. Evolving distribution channels, notably online sales and direct-to-consumer models, are changing how owners and veterinarians access products. As a result, organizations that integrate technological capability, regulatory foresight, and customer-centric distribution will capture differentiated value across species and markets.

Assessing how shifts in United States tariff policy could reshape supply chains, procurement decisions, and pricing dynamics for animal health stakeholders

Anticipated adjustments to United States tariff policy in 2025 present a complex set of implications for the animal health sector that extend beyond immediate cost pressures. Tariff changes tend to increase the landed cost of imported raw materials and finished products, which can compress margins for manufacturers reliant on international supply chains. In response, firms often reassess sourcing strategies, shifting toward nearer-shore suppliers or expanding domestic manufacturing capacity to mitigate exposure to trade policy volatility.

These adjustments also influence the logistics and timing of critical inputs such as vaccine components, diagnostic reagents, and specialized feed additives. Heightened customs clearance times and documentation requirements can create temporary bottlenecks that affect cold-chain continuity for biologics and time-sensitive deliveries for clinical diagnostics. As a consequence, distribution partners and veterinary clinics may adopt more conservative inventory practices, which can increase working capital needs and require more sophisticated demand forecasting capabilities.

Trade policy shifts frequently catalyze market realignment, with some countries diverting export flows away from tariff-affected routes and others capitalizing on competitive advantages to fill supply gaps. For companies, proactive measures include redesigning procurement contracts to include tariff pass-through clauses, investing in tariff classification expertise, and pursuing strategic inventory buffers at regional hubs. Importantly, pricing strategies must balance cost recovery with customer willingness to pay, and transparent communication with end users is essential to maintain trust during periods of cost adjustment. Over the medium term, firms that combine supply chain diversification, flexible manufacturing, and commercial agility will be best positioned to absorb policy-driven shocks while continuing to serve veterinarians, producers, and pet owners effectively.

Insights derived from a comprehensive segmentation framework that clarifies species, product modalities, therapeutic uses, distribution channels, and end-user behaviors

A nuanced segmentation framework reveals where clinical need, commercial opportunity, and operational complexity intersect across animal health portfolios. When viewed by animal type, the market spans companion animals and livestock; the companion animal segment concentrates on cats and dogs where preventive care, diagnostics, and chronic disease management dominate, while the livestock segment includes aquaculture, cattle, poultry, and swine, each with specific biosecurity, vaccination, and feed management priorities that reflect production systems and disease risk profiles.

Product-focused segmentation distinguishes diagnostics, feed additives, parasiticides, pharmaceuticals, and vaccines. Diagnostics bifurcate into immunological and molecular methods, enabling point-of-care screening and deeper genomic insights respectively. Feed additives encompass enzymes, prebiotics, and probiotics aimed at optimizing digestion and resilience, whereas parasiticides include ectoparasiticides and endoparasiticides tailored to species-specific parasite burdens. Pharmaceuticals split into branded and generic offerings, while vaccines cover killed inactivated, live attenuated, and recombinant formats with divergent manufacturing and regulatory pathways.

Therapeutic application segmentation clarifies clinical positioning across anti-infectives, anti-inflammatories, antiparasitics, and hormonal therapeutics. Anti-infectives further differentiate into antibiotics, antifungals, and antivirals, with stewardship pressures influencing use profiles. Anti-inflammatories are divided into corticosteroids and NSAIDs, reflecting efficacy and safety trade-offs. Antiparasitics include both ecto- and endoparasiticides, and hormonal therapeutics encompass growth and reproductive hormones used primarily in production settings.

Distribution channel segmentation exposes the shifting routes to market that affect reach and service models. Online stores, split between direct-to-consumer websites and third-party platforms, are expanding access and convenience; retail pharmacies, including chain and independent outlets, remain important for pet owners; and veterinary hospitals and clinics, ranging from large animal hospitals to small animal clinics, continue to be pivotal for prescribing and administering treatments. End-user segmentation identifies animal owners, feed manufacturers, and veterinarians as primary decision-makers, with animal owners comprising livestock farmers and pet owners, and veterinarians categorized into large animal, mixed practice, and small animal practitioners, each influencing product selection and adoption pathways.

Regional dynamics and regulatory environments that shape product adoption, supply chain design, and commercialization strategies across global animal health markets

Regional dynamics exert a strong influence on regulation, supply chains, and adoption rates across animal health markets. The Americas region presents a diverse profile: established regulatory frameworks, mature companion animal care markets, and large-scale commercial livestock operations with intensive biosecurity needs. In this geography, private veterinary practice and integrated production systems drive demand for diagnostics, vaccines, and feed optimization solutions, while digital channels increasingly supplement traditional distribution networks.

Europe, Middle East & Africa exhibits a multifaceted landscape shaped by stringent regulatory standards in many European markets, rising adoption of stewardship frameworks, and heterogeneity across Middle Eastern and African production systems. Demand in this region tends to prioritize high-quality vaccines and diagnostics, antimicrobial stewardship, and tailored support for smallholder and commercial producers. Infrastructure variability across countries underscores the need for adaptable distribution and cold-chain strategies.

The Asia-Pacific region is characterized by rapid modernization of production systems, significant aquaculture activity, and evolving companion animal care markets. Growing investment in local manufacturing and R&D coexists with reliance on cross-border trade for specialized inputs. Regulatory reform, increasing regulatory capacity, and strong private sector participation are accelerating uptake of advanced biologics and molecular diagnostics. Across regions, companies must tailor commercial approaches to regulatory environments, channel structures, and the varying priorities of veterinarians, producers, and pet owners.

Strategic playbooks adopted by industry leaders focusing on innovation, supply chain resilience, and go-to-market modernization to maintain competitive advantage

Leading companies in the sector are adopting strategic postures that emphasize R&D intensity, portfolio diversification, and channel innovation. Firms are allocating resources toward novel vaccine platforms and molecular diagnostics while expanding capabilities in feed additives and biologics that address antimicrobial stewardship concerns. Strategic alliances between pharmaceutical developers and technology vendors enable faster integration of diagnostic-guided treatment pathways and digital health services.

Commercially, organizations are optimizing distribution through a mix of direct-to-clinic relationships and digital sales channels. Investments in cold-chain logistics and regional manufacturing capacities reduce exposure to supply disruptions and trade policy shifts. In parallel, some companies are pursuing selective M&A to acquire complementary technologies, strengthen presence in high-growth species segments, or secure access to regional markets.

Operational excellence remains a priority: advanced quality systems, regulatory affairs expertise, and scalable contract manufacturing relationships support faster product launches and lifecycle management. Companies that balance innovation with pragmatic supply chain and commercialization strategies will sustain competitiveness. Moreover, sustained engagement with veterinarians and producers-through training, technical support, and performance data-sharing-reinforces product value propositions and drives adoption.

Practical high-impact actions for company executives to strengthen resilience, accelerate digital adoption, and drive clinical and commercial outcomes in animal health

Leaders in animal health should take decisive, actionable steps to capture opportunity and mitigate risk across a dynamic landscape. First, prioritize flexible manufacturing and supplier diversification to reduce exposure to policy-driven disruptions and logistics volatility. This includes validating alternative sources for critical inputs, investing in regional fill-finish capacity for biologics, and negotiating contracts that allow pricing adjustments aligned with input cost fluctuations.

Second, accelerate digital transformation initiatives that connect diagnostics to care pathways and enable telemedicine and remote monitoring for both companion animals and livestock. Integrating diagnostic data with treatment protocols enhances clinical outcomes and supports value-based conversations with payers and producers. Third, invest in antimicrobial stewardship and alternative therapeutics, pairing these efforts with educational programs for veterinarians and producers to drive responsible use and meet regulatory expectations.

Fourth, tailor commercial models by region and end user, combining direct engagement with veterinarians, digital DTC experiences for pet owners, and strategic partnerships with feed manufacturers. Finally, embed sustainability and transparency into product lifecycles-ranging from raw material sourcing to packaging choices-to address customer and regulatory demands and to differentiate brands over the long term. Implementing these actions in a coordinated manner will strengthen resilience, accelerate adoption, and create measurable value across portfolios.

A transparent, multi-method research approach combining primary interviews, secondary evidence synthesis, and rigorous triangulation to underpin strategic findings

This research synthesizes qualitative and quantitative approaches to produce a rigorous, actionable analysis. Primary research included structured interviews with veterinarians, production managers, procurement professionals, and industry experts to capture frontline perspectives on clinical needs, purchasing drivers, and distribution challenges. Complementing this, secondary research drew on regulatory publications, scientific literature, patent filings, and publicly available company disclosures to map technological trajectories and competitive positioning.

Data triangulation techniques validated insights across sources, ensuring consistency between field feedback and documented trends. Segmentation analyses employed species, product modality, therapeutic application, distribution channel, and end-user lenses to surface differentiated opportunities and constraints. Regional assessments combined policy reviews with logistics and infrastructure analyses to determine how geography shapes adoption and supply chain design.

Analytical rigor was maintained through iterative hypothesis testing, peer review, and scenario analysis to stress-test assumptions related to trade policy impacts and technology adoption. Limitations include variability in regulatory timelines across jurisdictions and heterogeneous data quality in certain regional contexts; these were addressed by transparency in assumptions and by prioritizing primary stakeholder input where secondary data were sparse. Ethical considerations upheld confidentiality and voluntary participation for all interview subjects.

A concise synthesis of sector dynamics that highlights the interplay of innovation, regulation, and operational resilience driving future animal health strategies

In conclusion, the animal health sector is experiencing a fundamental reconfiguration driven by technological innovation, regulatory evolution, and shifting commercial models. Advances in diagnostics and vaccine platforms, the rise of digital health and precision livestock farming, and growing emphasis on antimicrobial stewardship collectively reshape product development and service delivery. Simultaneously, supply chain resilience and regional strategy have become central to sustaining access to essential therapeutics and preventive products.

Industry participants that align R&D priorities with stewardship goals, invest in flexible manufacturing and regional distribution, and deploy customer-centric digital offerings will be better positioned to capture long-term value. Equally important is proactive engagement with regulatory authorities and veterinary communities to ensure that new modalities achieve clinical acceptance and regulatory compliance. By synthesizing practical operational measures with strategic investment in innovation, organizations can navigate near-term policy disruptions while building durable competitive advantage.

Looking forward, continued collaboration across the public and private sectors, coupled with evidence-driven commercialization and responsible use practices, will be essential to advancing animal health outcomes, protecting public health, and supporting sustainable food systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Animal Health Market, by Animal Type

  • 8.1. Companion Animals
    • 8.1.1. Cats
    • 8.1.2. Dogs
  • 8.2. Livestock
    • 8.2.1. Aquaculture
    • 8.2.2. Cattle
    • 8.2.3. Poultry
    • 8.2.4. Swine

9. Animal Health Market, by Product

  • 9.1. Diagnostics
    • 9.1.1. Immunological Diagnostics
    • 9.1.2. Molecular Diagnostics
  • 9.2. Feed Additives
    • 9.2.1. Enzymes
    • 9.2.2. Prebiotics
    • 9.2.3. Probiotics
  • 9.3. Parasiticides
    • 9.3.1. Ectoparasiticides
    • 9.3.2. Endoparasiticides
  • 9.4. Pharmaceuticals
    • 9.4.1. Branded
    • 9.4.2. Generics
  • 9.5. Vaccines
    • 9.5.1. Killed Inactivated
    • 9.5.2. Live Attenuated
    • 9.5.3. Recombinant

10. Animal Health Market, by Therapeutic Application

  • 10.1. Anti Infectives
    • 10.1.1. Antibiotics
    • 10.1.2. Antifungals
    • 10.1.3. Antivirals
  • 10.2. Anti Inflammatories
    • 10.2.1. Corticosteroids
    • 10.2.2. NSAIDs
  • 10.3. Antiparasitics
    • 10.3.1. Ectoparasiticides
    • 10.3.2. Endoparasiticides
  • 10.4. Hormonal Therapeutics
    • 10.4.1. Growth Hormones
    • 10.4.2. Reproductive Hormones

11. Animal Health Market, by Distribution Channel

  • 11.1. Online Stores
    • 11.1.1. Direct To Consumer Websites
    • 11.1.2. Third Party Platforms
  • 11.2. Offline
    • 11.2.1. Chain Pharmacies
    • 11.2.2. Independent Pharmacies

12. Animal Health Market, by End User

  • 12.1. Animal Owners
    • 12.1.1. Livestock Farmers
    • 12.1.2. Pet Owners
  • 12.2. Feed Manufacturers
  • 12.3. Veterinarians
    • 12.3.1. Large Animal Veterinarians
    • 12.3.2. Mixed Practice Veterinarians
    • 12.3.3. Small Animal Veterinarians

13. Animal Health Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Animal Health Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Animal Health Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Animal Health Market

17. China Animal Health Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Alltech, Inc.
  • 18.6. Boehringer Ingelheim International GmbH
  • 18.7. Cargill, Incorporated
  • 18.8. Ceva Sante Animale SA
  • 18.9. Chr. Hansen Holding A/S
  • 18.10. Covetrus, Inc.
  • 18.11. Dechra Pharmaceuticals PLC
  • 18.12. Elanco Animal Health Incorporated
  • 18.13. Heska Corporation
  • 18.14. HIPRA, S.A.
  • 18.15. Huvepharma AD
  • 18.16. IDEXX Laboratories, Inc.
  • 18.17. Kemin Industries, Inc.
  • 18.18. Koninklijke DSM N.V.
  • 18.19. Merck & Co., Inc.
  • 18.20. Neogen Corporation
  • 18.21. Phibro Animal Health Corporation
  • 18.22. Vetoquinol S.A.
  • 18.23. Virbac S.A.
  • 18.24. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANIMAL HEALTH MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ANIMAL HEALTH MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL HEALTH MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ANIMAL HEALTH MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ANIMAL HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ANIMAL HEALTH MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANIMAL HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DOGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DOGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL HEALTH MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL HEALTH MARKET SIZE, BY AQUACULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL HEALTH MARKET SIZE, BY AQUACULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL HEALTH MARKET SIZE, BY POULTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL HEALTH MARKET SIZE, BY POULTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL HEALTH MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SWINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SWINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANIMAL HEALTH MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANIMAL HEALTH MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ANIMAL HEALTH MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANIMAL HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ANIMAL HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANIMAL HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENZYMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PREBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PREBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PROBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANIMAL HEALTH MARKET SIZE, BY BRANDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ANIMAL HEALTH MARKET SIZE, BY BRANDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANIMAL HEALTH MARKET SIZE, BY BRANDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GENERICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GENERICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GENERICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANIMAL HEALTH MARKET SIZE, BY KILLED INACTIVATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ANIMAL HEALTH MARKET SIZE, BY KILLED INACTIVATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANIMAL HEALTH MARKET SIZE, BY KILLED INACTIVATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVE ATTENUATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVE ATTENUATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RECOMBINANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RECOMBINANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIFUNGALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIFUNGALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIVIRALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIVIRALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CORTICOSTEROIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CORTICOSTEROIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANIMAL HEALTH MARKET SIZE, BY NSAIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ANIMAL HEALTH MARKET SIZE, BY NSAIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANIMAL HEALTH MARKET SIZE, BY NSAIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GROWTH HORMONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GROWTH HORMONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GROWTH HORMONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANIMAL HEALTH MARKET SIZE, BY REPRODUCTIVE HORMONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ANIMAL HEALTH MARKET SIZE, BY REPRODUCTIVE HORMONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANIMAL HEALTH MARKET SIZE, BY REPRODUCTIVE HORMONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIRECT TO CONSUMER WEBSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIRECT TO CONSUMER WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIRECT TO CONSUMER WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THIRD PARTY PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THIRD PARTY PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THIRD PARTY PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL ANIMAL HEALTH MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL ANIMAL HEALTH MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL ANIMAL HEALTH MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL ANIMAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL ANIMAL HEALTH MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL ANIMAL HEALTH MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL ANIMAL HEALTH MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK FARMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK FARMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK FARMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PET OWNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PET OWNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PET OWNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VETERINARIANS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VETERINARIANS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VETERINARIANS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VETERINARIANS, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LARGE ANIMAL VETERINARIANS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LARGE ANIMAL VETERINARIANS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LARGE ANIMAL VETERINARIANS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL ANIMAL HEALTH MARKET SIZE, BY MIXED PRACTICE VETERINARIANS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL ANIMAL HEALTH MARKET SIZE, BY MIXED PRACTICE VETERINARIANS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL ANIMAL HEALTH MARKET SIZE, BY MIXED PRACTICE VETERINARIANS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SMALL ANIMAL VETERINARIANS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SMALL ANIMAL VETERINARIANS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SMALL ANIMAL VETERINARIANS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL ANIMAL HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 179. AMERICAS ANIMAL HEALTH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 180. AMERICAS ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. AMERICAS ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 182. AMERICAS ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 183. AMERICAS ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 184. AMERICAS ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 185. AMERICAS ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 186. AMERICAS ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 187. AMERICAS ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 188. AMERICAS ANIMAL HEALTH MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 189. AMERICAS ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. AMERICAS ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 191. AMERICAS ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 192. AMERICAS ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 193. AMERICAS ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 194. AMERICAS ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. AMERICAS ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 196. AMERICAS ANIMAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 197. AMERICAS ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. AMERICAS ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, 2018-2032 (USD MILLION)
  • TABLE 199. AMERICAS ANIMAL HEALTH MARKET SIZE, BY VETERINARIANS, 2018-2032 (USD MILLION)
  • TABLE 200. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 204. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 206. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 208. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 210. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 212. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 214. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 218. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, 2018-2032 (USD MILLION)
  • TABLE 220. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY VETERINARIANS, 2018-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 224. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 226. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 228. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 230. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 234. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 236. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 238. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, 2018-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY VETERINARIANS, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY VETERINARIANS, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPE ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPE ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPE ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPE ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPE ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPE ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPE ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPE ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPE ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPE ANIMAL HEALTH MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPE ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPE ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPE ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPE ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPE ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPE ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPE ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPE ANIMAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPE ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPE ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPE ANIMAL HEALTH MARKET SIZE, BY VETERINARIANS, 2018-2032 (USD MILLION)
  • TABLE 284. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 285. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 288. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 289. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 290. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 291. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 292. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 294. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 296. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 298. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 300. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 301. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 302. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 303. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, 2018-2032 (USD MILLION)
  • TABLE 304. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY VETERINARIANS, 2018-2032 (USD MILLION)
  • TABLE 305. AFRICA ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 306. AFRICA ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 307. AFRICA ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 308. AFRICA ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 309. AFRICA ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 310. AFRICA ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 311. AFRICA ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 312. AFRICA ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 313. AFRICA ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 314. AFRICA ANIMAL HEALTH MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 315. AFRICA ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 316. AFRICA ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 317. AFRICA ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 318. AFRICA ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 319. AFRICA ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 320. AFRICA ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 321. AFRICA ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 322. AFRICA ANIMAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 323. AFRICA ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 324. AFRICA ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, 2018-2032 (USD MILLION)
  • TABLE 325. AFRICA ANIMAL HEALTH MARKET SIZE, BY VETERINARIANS, 2018-2032 (USD MILLION)
  • TABLE 326. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 327. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 329. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 330. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 331. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 332. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 333. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 334. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 335. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 336. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 337. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 338. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 339. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
  • TABLE 340. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 341. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 342. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 343. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 344. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MI